Bolus/infusional 5-fluorouracil and folinic acid for metastatic colorectal carcinoma: are suboptimal dosages being used in the UK?

Bolus/infusional 5-fluorouracil (5-FU) and folinic acid (FA) is reported to be highly active [partial response (PR) = 54%, median survival 18 months] in patients with metastatic colorectal carcinoma (MCCa). To confirm this level of activity, we conducted a retrospective analysis of 95 previously unt...

Descripción completa

Detalles Bibliográficos
Autores principales: Jodrell, D. I., Murray, L. S., Reed, N. S., Canney, P. A., Kaye, S. B., Cassidy, J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033392/
https://www.ncbi.nlm.nih.gov/pubmed/7917933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033392/
https://www.ncbi.nlm.nih.gov/pubmed/7917933

Ejemplares similares